eli lily tirzepatide Lilly's scores again, this time in 2 sleep apnea trials Lilly's tirzepatide slashes risk of

published in Diabetes, Obesity and Metabolism confirmed that once-weekly semaglutide 2.4mg produced a mean body weight reduction of 11.80% compared to placebo in non-diabetic adults with obesity, with results shown to be safe and well tolerated

Dairy is typically seen as a food group that has a health halo

For example, if you carry variants associated with stronger appetite drive, continuous or episodic maintenance therapy may align better with your biology than assuming a one-time treatment suffices

Tirzepatide In 2026, the landscape of metabolic health in Morristown looks vastly different than it did just three years ago